BMJ · 2016 · 24 citations · 0 references
MedicineChild HealthPediatricsAdolescent HealthDiabetologyPediatric EndocrinologyDiabetes ControlDiabetes ManagementDiabetes MellitusDiabetic KetoacidosisDiabetic Ketoacidosis CareGlycemic ControlComparative Cost-effectivenessCost-effectivenessDiabetes Management In ChildrenDiabetes Mellitus AssessmentDiabetic Ketoacidosis AssessmentDiabetic Ketoacidosis ManagementPediatric Diabetic Ketoacidosis
#### What you need to know Type 1 diabetes affects more than 25 000 children and young people in the United Kingdom and type 2 affects about 500, with both types becoming more common.1 Life threatening complications, including diabetic ketoacidosis (DKA), can occur with both type 1 and type 2 diabetes. Prompt recognition and effective management of diabetes and associated complications are essential. This article summarises new recommendations from the National Institute for Health and Care Excellence (NICE), which for the first time cover type 2 diabetes and the recognition and management of DKA in children and young people.2 #### What’s new in this guidance? NICE recommendations are based on systematic reviews of best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on the Guideline Development Group’s experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets. ### General principles #### Type 1 and type 2 diabetes: recognition, diagnosis, and referral